Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Cardiol Therapeutics Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 35 | 32 | −3 |
| Shares | 6.37M | 6.92M | +542.2K (+8.5%) |
| Value | $5.78M | $6.02M | +$242.2K (+4.2%) |
New holders (3)
Institutions that held Cardiol Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lion Street Advisors, LLC | 192,700 | $160.8K | 0.07% |
| Raymond James & Associates | 11,154 | $9.40K | 0.00% |
| Advisory Services Network, LLC | 3,458 | $2.92K | 0.00% |
Sold out (6)
Institutions that held Cardiol Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| FNY Investment Advisers, LLC | 33,305 | $30.0K |
| MONECO Advisors, LLC | 14,000 | $12.5K |
| HRT Financial LP | 12,345 | $11.0K |
| Wells Fargo & Company | 150 | $137 |
| Morgan Stanley | 100 | $90 |
| Simplex Trading, LLC | 1,054 | $0 |